课题基金 / 基金详情

Tiered Testing Strategy for Assessing Thermal Effects on Transdermal Products

Tiered Testing Strategy for Assessing Thermal Effects on Transdermal Products
评估透皮产品热效应的分层测试策略
批准号:
8692359
负责人:
Kevin S. Li
金额:
$49.44万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-09-15 至 2016-08-31

项目摘要

项目成果

Kevin S. Li的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Many transdermal systems are affected by temperature and are labeled with a warning against heat application. For example, heat can increase skin permeability. Heat can affect drug solubility in a formulation and drug (and excipient) release from the transdermal system. Heat can also increase dermal clearance and systemic drug absorption via the vascular network. Heat effects can be different among different transdermal delivery systems. In the FDA review process, when the reference product has a label warning against heat application, the generic product cannot be more sensitive to heat than the reference product. Different heat effects among transdermal products can be due to different drug release (and formulation release) from the products. In addition, due to the different formulation release under heat, these formulations can exert different effects on skin permeability. The different formulation release and penetration into the dermis can also affect dermal clearance for systemic drug absorption. The objectives of this project are to (a) investigate the in vitro release test conditions for identifying heat effects on transdermal delivery and (b) develop an in vitro test process to be used in the reviews of transdermal products to ensure that generic products do not introduce any additional safety risks. We will evaluate the influence of heat upon the rate of drug release from the patch using in vitro release testing of USP dissolution apparatus (tier 1), drug and formulation permeation across skin using Franz diffusion cells (tier 2), and dermal clearance analyses using an existing, state-of-the-art, skin diffusion model to determine dermis concentration and drug absorption into the vascular network in the dermis (tier 3). It is hypothesize that this tiered in vitro testing strategy will yield a scientifically-based decision tree to support the evaluation of thermal effects for ANDA approvals of transdermal products.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
RNA Nanosystem for Posterior Eye Drug Delivery
  • 批准号:
    10322457
  • 项目类别:
  • 资助金额:
    $39.57万
  • 财政年份:
    2021
  • 负责人:
    Kevin S. Li
  • 依托单位:
RNA Nanosystem for Posterior Eye Drug Delivery
  • 批准号:
    10560482
  • 项目类别:
  • 资助金额:
    $40.13万
  • 财政年份:
    2021
  • 负责人:
    Kevin S. Li
  • 依托单位:
Characterization of gingival drug delivery to improve local treatment
  • 批准号:
    9812590
  • 项目类别:
  • 资助金额:
    $48.1万
  • 财政年份:
    2019
  • 负责人:
    Kevin S. Li
  • 依托单位:
RNA Nanoparticles for Ocular Drug Delivery to the Posterior Eye
  • 批准号:
    8819591
  • 项目类别:
  • 资助金额:
    $24.78万
  • 财政年份:
    2014
  • 负责人:
    Kevin S. Li
  • 依托单位:
海外基金